References
- Fava M, Davidson, KG: Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am. 1996; 19(2):179–200
- Nierenberg AA, Wright EC: Evolution of remission as the new standard in the treatment of depression. J Clin Psychiatry. 1999; 60\(Suppl. 22):7–11
- Fava M. Kaji J: Continuation and maintenance treatments of major depressive disorder. Psychiatr Ann 1994; 42:281–290
- Fava M: New approaches to the treatment of refractory de-pression. J Clin Psychiatry 2000: 61\(Suppl. 1):26–32
- Fredman SJ, Fava M, Kienke AS, White CN, Nierenberg AA, Rosenbaum JF: Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depres-sion: A survey of current "next-step" practices. J Clin Psychi-atry 2000; 61(6):403–408
- First BM, Spitzer RL, Gibbon M. Williams JBW: Structured clinical interview for DSNI-IV Axis I Disorders—Patient Edi-tion (SCID UP). Biometrics Research Department, New York State Psychiatric Institute; 1995
- Guy W (ed.): ECDEU Assessment Manual for Psychopharma-cology, Revised, DHEW Pub. No. (ADM) 76–338. Rockville, MD; National Institute of Mental Health; 1976
- Hamilton M: A rating scale for depression. J Neurol NeurosurgPsychiatry 1960; 23:56–62
- Fava M: Management of nonresponse and intolerance: Switch-ing strategies. J Clin Psychiatry 2000; 61\(Suppl. 2):10--12
- Goodnick PJ, Sandoval R, Brickman A, Klimas NG: Bupro-pion treatment of fluoxetine-resistant chronic fatigue syn-drome. Biol Psychiatry 1992; 32:834–838
- Walker PW, Cole JO, Gardner EA, Hughes AR, Johnson A, Batey SR, Lineberry CG: Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion. J Clin Psychiatry 1993; 54(12):459–565
- Fava M: Weight gain and antidepressants. J Clin Psychiatry 2000; 61 (Suppl. 11):37–41
- Modell JG, Katholi CR, Modell JD, DePalma RL: Com-parative sexual side effects of bupropion, fluoxetine, parox-etine and sertraline. Clin Pharmacol Ther 1997; 61:476–487
- Clayton AH, Pradko JF, Croft HA, Montano CB, Leadbetter RA, Bolden-Watson C, Bass KI, Donahue RM, Jamerson BD, Metz A: Prevalence of sexual dysfunction among newer an-tidepressants. J Clin Psychiatry 2002; 63(4):357–366
- Joffe RT, Levitt AJ, Sokolov STH, Young LT: Response to an open trial of a second SSRI in major depression. J Clin Psychiatry 1996; 57(3):114–115
- Thase ME, Sharon SL, Birkett MA, Apter JT, Rosalinda GT: Fluoxetine treatment of patients with major depressive disor-der who failed initial treatment with sertraline. J Clin Psychi-atry 1997; 58(1):16–34
- Bodkin JA, Lasser RA, Wines JD, Gardner DM, Baldessarini RJ: Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy. J Clin Psychiatry 1997; 58:(4):137–145
- Thase ME, Frank E, Mallinger AG, Hamer T, Kupfer DJ: Treatment of imipramine-resistant recurrent depression III: Efficacy of monoamine oxidase inhibitors. J Clin Psychiatry 1992; 53:5–11
- Nierenberg A, Papakostas GI, Petersen T, Worthington JJ III, Tedlow J, Alpert JE, Fava M: Lithium augmentation of nor-triptyline for subjects resistant to multiple antidepressants. J Clin Psychopharmacol 2003; 23(1):92–95